Next Article in Journal
Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment
Next Article in Special Issue
A Geant4-DNA Evaluation of Radiation-Induced DNA Damage on a Human Fibroblast
Previous Article in Journal
Automated Raman Micro-Spectroscopy of Epithelial Cell Nuclei for High-Throughput Classification
Previous Article in Special Issue
On the Equivalence of the Biological Effect Induced by Irradiation of Clusters of Heavy Atom Nanoparticles and Homogeneous Heavy Atom-Water Mixtures
 
 

Order Article Reprints

Journal: Cancers, 2021
Volume: 13
Number: 4768

Article: Biological Impact of Target Fragments on Proton Treatment Plans: An Analysis Based on the Current Cross-Section Data and a Full Mixed Field Approach
Authors: by Elettra Valentina Bellinzona, Leszek Grzanka, Andrea Attili, Francesco Tommasino, Thomas Friedrich, Michael Krämer, Michael Scholz, Giuseppe Battistoni, Alessia Embriaco, Davide Chiappara, Giuseppe A. P. Cirrone, Giada Petringa, Marco Durante and Emanuele Scifoni
Link: https://www.mdpi.com/2072-6694/13/19/4768

MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.

If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.

Reprint Options

If you need more than 400 copies, please contact us by e-mail (publisher@mdpi.com) and we will prepare an individual offer for you.

Order Cost and Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop